Samuel Broder - 12 May 2021 Form 3 Insider Report for Orion Biotech Opportunities Corp.

Role
Director
Signature
/s/ Marcello Liguori as attorney in fact for Samuel Broder
Issuer symbol
N/A
Transactions as of
12 May 2021
Net transactions value
$0
Form type
3
Filing time
12 May 2021, 21:54:40 UTC
Next filing
14 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ORIA Class B ordinary shares 12 May 2021 Class A ordinary shares 40,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the issuer's registration statement on Form S-1 (File No. 333-253548) under the heading "Description of Securities-Founder Shares", the Class B ordinary shares, par value $0.0001, will automatically convert into Class A ordinary shares, par value $0.0001, of the issuer at the time of the issuer's initial business combination transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney